Presentation TCT 2016 MATRIX Critique: Pros and Cons Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit October 31, 2016
Presentation TCT 2016 Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta October 31, 2016
Presentation TCT 2015 MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS Presenter: Carlo Briguori, Roxana Mehran October 15, 2015
Presentation TCT 2015 HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Statistical Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Stuart J. Pocock October 12, 2015
Presentation TCT 2015 HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Gregg W. Stone October 12, 2015
Presentation Post-ESC_15 Late-Breaking Trial Webcast: MATRIX Duration, OPTIDUAL, and PLATFORM Presenter: Gregg W. Stone September 15, 2015